DealBook: AstraZeneca Rejects ‘Final’ Offer by Pfizer
The latest rebuff may mean the end of Pfizer’s pursuit of a merger. The American company has said it would not make a hostile bid for AstraZeneca. The Anglo-Swedish drug maker said Sunday’s $119 billion offer undervalued the company. [Source]
Publication Date:Origin: nytimes.com
Category: United States
Topics: company, AstraZeneca, undervalued, offer, billion, Sunday’s, maker, Anglo-Swedish, hostile, would, American, merger, pursuit, Pfizer’s, rebuff, latest, Pfizer, Offer, ‘Final’, Rejects, DealBook